Phase 3 Clinical Trial for Systemic Scleroderma Resumes Recruiting Patients
source: pixabay.com

Phase 3 Clinical Trial for Systemic Scleroderma Resumes Recruiting Patients

According to a story from PR Newswire, the drug company CiVi Biopharma, Inc. today announced that its subsidiary Eicos Sciences, Inc. has resumed recruiting patients for its phase 3 clinical…

Continue Reading Phase 3 Clinical Trial for Systemic Scleroderma Resumes Recruiting Patients
Overview: Identifying and Managing 3 Scleroderma Emergencies
source: pixabay.com

Overview: Identifying and Managing 3 Scleroderma Emergencies

  Thanks to the rampant spread of COVID-19, many events, symposiums, and clinics moved online. One was the 2020 ACR State-of-the-Art Clinical Symposium, in which participants discuss diagnostic information, treatments,…

Continue Reading Overview: Identifying and Managing 3 Scleroderma Emergencies
June is Scleroderma Awareness Month: Spreading Rare Disease Awareness
source: pixabay.com

June is Scleroderma Awareness Month: Spreading Rare Disease Awareness

According to a story from Scleroderma News, June is recognized as Scleroderma Awareness Month. While physical distancing as a result of the ongoing coronavirus/COVID-19 pandemic may keep some folks at…

Continue Reading June is Scleroderma Awareness Month: Spreading Rare Disease Awareness